Effect of polyanion-resistance on HIV-1 infection

被引:19
|
作者
Bobardt, MD
Armand-Ugón, M
Clotet, I
Zhang, Z
David, G
Este, JA
Gallay, PA
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Hosp Germans Trias & Pujol, Retrovirol Lab IrsiCaixa, Badalona 08916, Spain
[3] Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[4] Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium
关键词
polyanion; HIV-1; T cell;
D O I
10.1016/j.virol.2004.05.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Polyanions are potent HIV-1 entry inhibitors. Nevertheless, resistant viruses may emerge under polyanion inhibitory pressure. Specifically.. a polyanion-resistant virus replicates in T cells even in the presence of high concentrations of polyanions. We found that although the polyanion-resistant virus grows in suspension CD4+ T cells efficiently, it infects nonlymphocytic adherent CD4+ cells poorly. Given that a main distinction between suspension and adherent cells is the absence or presence of cell-surface heparan sulfate proteoglycan (HSPG), we investigated if the failure of the polyanion-resistant virus to infect adherent CD4+ cells arises from its inability to bind HSPG. We found that the emergence of mutations in gp120 associated with polyanion resistance resulted in a decreased capacity of HIV-1 to bind HSPG. We also found that the polycation polybrene rescued the capacity of the polyanion-resistant virus to bind HSPG and to infect adherent CD4+ cells. The identification of this virus, unable to bind HSPG, provides a convenient probe to measure the impact of HIV-1-HSPG interactions in vivo. Altogether, these findings suggest that polyanion-resistance narrows the range of potential target cells for HIV-1 in the host. This reinforces the hypothesis that cell-free or cell-associated polyanions such as HSPG possess the capacity to modulate HIV-1 pathogenesis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 50 条
  • [41] Primary drug resistance at diagnosis of HIV-1 infection: a Portuguese cohort
    Pereira, Nuno Rocha
    Duro, Raquel
    Pinero, Carmela
    Ofigueiredo, Cristova
    Santos, Ana Soa
    Soares, Jorge
    Serrao, Rosario
    Sarmento, Antonio
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 163 - 164
  • [42] The role of baseline HIV-1 resistance testing in patients with established infection
    Chan S.-Y.
    Hulgan T.
    D'Aquila R.T.
    Current Infectious Disease Reports, 2004, 6 (3) : 243 - 249
  • [43] Pre-existence and emergence of drug resistance in HIV-1 infection
    Bonhoeffer, S
    Nowak, MA
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1997, 264 (1382) : 631 - 637
  • [44] The role of antiretrovirals and drug resistance in vertical transmission of HIV-1 infection
    Brenner, BG
    Wainberg, MA
    PREVENTION AND TREATMENT OF HIV INFECTION IN INFANTS AND CHILDREN, 2000, 918 : 9 - 15
  • [45] Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection
    Derache, Anne
    Wallis, Carole L.
    Vardhanabhuti, Saran
    Bartlett, John
    Kumarasamy, Nagalingeswaran
    Katzenstein, David
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (02): : 250 - 256
  • [46] Pediatric HIV-1 infection
    Melvin, AJ
    Frenkel, LM
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1997, 24 (04) : 911 - &
  • [47] Immunophilins and HIV-1 infection
    Minder, D
    Böni, J
    Schüpbach, J
    Gehring, H
    ARCHIVES OF VIROLOGY, 2002, 147 (08) : 1531 - 1542
  • [48] Paediatric HIV-1 infection
    Burns, DN
    Mofenson, LM
    LANCET, 1999, 354 : S1 - S6
  • [49] Apoptosis in HIV-1 infection
    Bell, DJ
    Dockrell, DH
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (02) : 178 - 183
  • [50] Engineering Resistance to HIV-1 Infection with a Dual Therapeutic Lentiviral Vector
    Burke, Bryan P.
    Boyd, Maureen P.
    Millington, Michelle L.
    Impey, Helen
    Zhang, Jane
    Carroll, Maria V.
    Camba-Colon, Joanna
    Keech, Naomi
    Delebecque, Frederic
    Wolstein, Orit
    Howe, Annett
    Koldej, Rachel
    Nicolson, Tamara
    Levin, Bernard R.
    Rezek, Valerie
    Vatakis, Dimitrios N.
    Kitchen, Scott G.
    Breton, Louis R.
    Bartlett, Jeffrey S.
    Symonds, Geoff P.
    MOLECULAR THERAPY, 2013, 21 : S20 - S20